Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling

  • The PLOS ONE Staff

Correction: Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling

  • The PLOS ONE Staff
PLOS
x

There are some missing funding sources for this article. Please refer to the correct funding statement below:

The studies in this manuscript were funded by Exelixis Inc.; PO1 National Institutes of Health grant (PO1CA085859); Pacific Northwest Prostate Cancer SPORE grant (P50CA097186); Prostate Cancer Foundation; Richard M. Lucas Foundation; and University of Washington Bridge funding. Two of the co-authors (DTA and FS) are employees of Exelixis. They were involved in study design, data analyses, decision to publish and preparation of the manuscript.

Reference

  1. 1. Nguyen HM, Ruppender N, Zhang X, Brown LG, Gross TS, et al. (2013) Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling. PLoS ONE 8(10): e78881